The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys.
about
Pharmacological Targeting of the Hepcidin/Ferroportin AxisHepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic ReviewLaboratory use of hepcidin in renal transplant recipientsMolecular Selection, Modification and Development of Therapeutic Oligonucleotide AptamersNucleic acid aptamers: research tools in disease diagnostics and therapeuticsIron regulation by hepcidinSuppression of iron-regulatory hepcidin by vitamin DHepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in ratsAnemia of Inflammation: A Review.Hepcidin and sports anemiaHepcidin antagonists for potential treatments of disorders with hepcidin excess.Hepcidin-dependent and hepcidin-independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation.Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans.Iron and inflammation - the gut reaction.RAP-011, an activin receptor ligand trap, increases hemoglobin concentration in hepcidin transgenic miceAn L-RNA Aptamer that Binds and Inhibits RNase.Specific Inhibition of MicroRNA Processing Using L-RNA Aptamers.Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjectsModulation of hepcidin to treat iron deregulation: potential clinical applications.Effects of Testosterone on Erythropoiesis in a Female Mouse Model of Anemia of InflammationA mixed mirror-image DNA/RNA aptamer inhibits glucagon and acutely improves glucose tolerance in models of type 1 and type 2 diabetes.Out of balance--systemic iron homeostasis in iron-related disordersHepcidin regulation in the anemia of inflammationA novel C5a-neutralizing mirror-image (l-)aptamer prevents organ failure and improves survival in experimental sepsisThe iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients.BuMPing iron with modified heparins.Effects of Anti-repulsive Guidance Molecule C (RGMc/Hemojuvelin) Antibody on Hepcidin and Iron in Mouse Liver and Tumor XenograftsInduced Disruption of the Iron-Regulatory Hormone Hepcidin Inhibits Acute Inflammatory HypoferraemiaManipulation of the hepcidin pathway for therapeutic purposes.Anemia of inflammationHow do we treat life-threatening anemia in a Jehovah's Witness patient?Aptamers as targeted therapeutics: current potential and challenges.Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis.Status and Prospects of Aptamers as Drug Components.Experimental and investigational therapies for chemotherapy-induced anemia.Anaemia of Chronic Disease: An In-Depth Review.Investigational therapies for renal disease-induced anemia.Role of hepcidin-ferroportin axis in the pathophysiology, diagnosis, and treatment of anemia of chronic inflammation.Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.Identification of Guanosine 5'-diphosphate as Potential Iron Mobilizer: Preventing the Hepcidin-Ferroportin Interaction and Modulating the Interleukin-6/Stat-3 Pathway.
P2860
Q26738350-BB76FED5-2A97-418B-816E-1EC714D2D080Q26750731-D67CA396-4193-47B4-8081-3096A0EB0850Q26765316-BCF4A705-789C-4B6E-9AB3-86572D11C86AQ26765458-1A17726F-6728-4C1B-AB7E-57505B0690C6Q26824321-8809E078-575F-4C6C-863E-C60962ABD4ACQ28291718-BB484426-E6AD-4FA0-AD33-118B8A8E5CCCQ28301486-A94BB62F-02E2-4F55-802E-9ACA1FAF9E28Q28568757-CCC9A89F-9D84-4FF7-B286-2F2D24D8C5BCQ30235957-13545653-D0CB-437B-BCBF-3D6B19F2A100Q33559763-DCF5AF24-633C-4674-AB88-61F7A1CE6049Q33563777-02F881FE-5835-4E32-8197-3DEED9D67CEEQ34356512-E06A723D-6676-481F-B15A-9E4DC2F37BC1Q34398348-3717DEA1-12DD-443B-AFA2-CB97DA73EC8CQ34548797-6831BAA3-99AF-4625-8B46-2B2368DBB5E6Q34771518-668078ED-853C-4B5A-94FC-1F4F1BA4D6A7Q36307747-4B355D1F-ED17-4C53-A13F-F6291FBA0392Q36435625-6B6C2B22-AC11-42C3-9FBC-9DFAAB8BE7FDQ36830103-BD55E83B-F006-4CE1-805C-B1D912A86490Q36847852-BF452D6E-61EB-4A91-A1F7-F7D734610D0CQ37057480-A0B8BEDE-22CC-45B5-AC8C-691FE5EAD506Q37175145-EF69B7B6-27CC-4F62-8EE5-6B1D5C260180Q37177398-41B4A65B-734B-437B-9EB7-D1D9EC299DE7Q37193954-30300EFF-2277-425E-95F8-7A8A812F5786Q37393792-209D09BB-EE7C-49C4-A563-5BF9CA793201Q37542851-2BF440E0-CE50-46DB-A9D0-B7A17C4D1E13Q37623520-A30618A2-AD37-496D-A764-CA6396A719D3Q37638804-FFE6BFC7-09DC-4DC9-9D7D-8AE11AF8EB49Q37661418-B34DBEAB-9EC7-4417-BB5E-EE351728CE24Q38159513-8A743670-6FC4-4777-A90E-DA4EC9FD8FE2Q38234242-CB55A88F-8417-4ED9-880D-521E7999AE2EQ38261467-86E5CE11-D7A9-4149-8298-F2B50468208CQ38290290-40BEA836-38C0-4B80-A260-7BE0302D613DQ38307041-2831713D-A81F-4654-9292-7864D58DFAE4Q38488502-F2604A22-5BC2-4654-B973-2004B259F37DQ38584639-4B878374-F2B3-4C59-8EEA-7F0773F631C5Q38809858-4A5E658D-5322-4D1A-B831-90E3BB6E8F1AQ38819455-DC86920B-917D-4D6F-9333-ADB9B034BC39Q39192994-866C03E6-4746-475D-B02E-903FFF83B188Q39313303-5C8BDB99-E60F-4983-9DE6-D1107977723EQ40776456-4AC564F5-DBA6-466F-B8B3-509AF20F2170
P2860
The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The effects of the anti-hepcid ...... anemia in cynomolgus monkeys.
@ast
The effects of the anti-hepcid ...... anemia in cynomolgus monkeys.
@en
The effects of the anti-hepcid ...... anemia in cynomolgus monkeys.
@nl
type
label
The effects of the anti-hepcid ...... anemia in cynomolgus monkeys.
@ast
The effects of the anti-hepcid ...... anemia in cynomolgus monkeys.
@en
The effects of the anti-hepcid ...... anemia in cynomolgus monkeys.
@nl
prefLabel
The effects of the anti-hepcid ...... anemia in cynomolgus monkeys.
@ast
The effects of the anti-hepcid ...... anemia in cynomolgus monkeys.
@en
The effects of the anti-hepcid ...... anemia in cynomolgus monkeys.
@nl
P2093
P2860
P1433
P1476
The effects of the anti-hepcid ...... anemia in cynomolgus monkeys.
@en
P2093
Christian Maasch
Dirk Eulberg
Dirk Zboralski
Frank Morich
Frank Schwoebel
Klaus Buchner
Lucas T van Eijk
Martin Humphrey
Peter Pickkers
Simone Sell
P2860
P304
P356
10.1182/BLOOD-2012-09-456756
P407
P577
2013-01-24T00:00:00Z